Transdermal delivery of ketorolac tromethamine: Effects of vehicles and penetration enhancers

被引:42
|
作者
Cho, YA [1 ]
Gwak, HS [1 ]
机构
[1] Chosun Univ, Coll Pharm, Kwangju 501759, South Korea
关键词
transdermal delivery; ketorolac tromethamine; vehicles; penetration enhancers;
D O I
10.1081/DDC-120037486
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The effects of vehicles and penetration enhancers on the in vitro permeation of ketorolac tromethamine (KT) across excised hairless mouse skins were investigated. Among pure vehicles examined, propylene glycol monolaurate (PGML) showed the highest permeation flux, which was 94.3 +/- 17.3 mug/cm(2)/h. Even though propylene glycol monocaprylate (PGMC) alone did not show high permeation rate, the skin permeability of KT was markedly increased by the addition of diethylene glycol monoethyl ether (DGME); the enhancement factors were 19.0 and 17.1 at 20% and 40% of DGME, respectively. When DGME was added to PGML, the permeation fluxes were almost two times at 20-60% of DGME compared to PGML alone. In the cosolvent system consisting of propylene glycol (PG)-oleyl alcohol, the permeation rate increased as the ratio of PG increased. In the study to investigate the effect of drug concentration on the permeation rate of KT, the permeation rates increased as the drug concentration increased in all vehicles used, and the dramatic increase in permeation rate was obtained when the drug concentration was higher than its solubility. For the effects of fatty acids on the permeation of KT, five fatty acids were added to PG at concentrations of 1%-, 3%-, 5%- and 10%- caprylic acid, capric acid, lauric acid, oleic acid, and linoleic acid. The enhancing effects of fatty acids were different, depending on the concentration as well as the sort of fatty acids. The highest enhancing effect was attained with 10% caprylic acid in PG; the permeation flux was 113.6 +/- 17.5 mug/cm(2)/h. The lag time of KT was reduced as the concentration of fatty acids increased except for caprylic acid.
引用
收藏
页码:557 / 564
页数:8
相关论文
共 50 条
  • [1] Transdermal Delivery of Ketorolac Tromethamine Using Microemulsion Vehicles
    Salimi, Anayatollah
    Jafarinezhad, Shadi
    Kalantari, Azin
    JUNDISHAPUR JOURNAL OF NATURAL PHARMACEUTICAL PRODUCTS, 2018, 13 (04)
  • [2] Transdermal delivery of ondansetron hydrochloride: Effects of vehicles and penetration enhancers
    Gwak, HS
    Oh, IS
    Chun, IK
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2004, 30 (02) : 187 - 194
  • [3] Effects of vehicles and enhancers on transdermal delivery of melatonin
    Oh, HJ
    Oh, YK
    Kim, CK
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 212 (01) : 63 - 71
  • [4] Effects of vehicles and enhancers on transdermal delivery of clebopride
    Yun-Seok Rhee
    Jai-Yong Huh
    Chun-Woong Park
    Tae-Young Nam
    Koog-Ryul Yoon
    Sang-Cheol Chi
    Eun-Seok Park
    Archives of Pharmacal Research, 2007, 30
  • [5] Effects of vehicles and enhancers on transdermal delivery of clebopride
    Rhee, Yun-Seok
    Huh, Jai-Yong
    Park, Chun-Woong
    Nam, Tae-Young
    Yoon, Koog-Ryul
    Chi, Sang-Cheol
    Park, Eun-Seolk
    ARCHIVES OF PHARMACAL RESEARCH, 2007, 30 (09) : 1155 - 1161
  • [6] IMPACTS OF KETOROLAC TROMETHAMINE IN TRANSDERMAL DRUG DELIVERY SYSTEM
    Jha, Amit Kumar
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2010, 1 (12): : 56 - 61
  • [7] Formulation and Development of Proniosomal Gel for Transdermal Delivery of Ketorolac Tromethamine
    Farooqui, Nadeem
    Kar, Mousumi
    Singh, Ravindra Pal
    ASIAN JOURNAL OF PHARMACEUTICS, 2016, 10 (03) : S394 - S400
  • [8] Effect of Penetration Enhancers on Transdermal Delivery of Propofol
    Yamato, Keisuke
    Takahashi, Yuri
    Akiyama, Hidero
    Tsuji, Kazuyuki
    Onishi, Hiraku
    Machida, Yoshiharu
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2009, 32 (04) : 677 - 683
  • [9] Lipid Nanocapsule-Based Gels for Enhancement of Transdermal Delivery of Ketorolac Tromethamine
    Varshosaz, Jaleh
    Hajhashemi, Valiollah
    Soltanzadeh, Sindokht
    JOURNAL OF DRUG DELIVERY, 2011, 2011
  • [10] APPLICATION SITE AND GENDER DIFFERENCES IN PHARMACOKINETICS FOR A KETOROLAC TROMETHAMINE TRANSDERMAL DELIVERY SYSTEM
    COMBS, D
    MROSZCZAK, E
    JUAN, D
    IPE, D
    YU, S
    ROCHA, C
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 181 - 181